|
GlaxoSmithKline patient assistance programs provided medicines valued at almost $388 million (Wholesale Acquisition Cost) to more than 484,000 patients during 2007.
Bridges to Access provides free or low-cost GSK medicines to eligible low-income patients without prescription drug benefits who are not enrolled in Medicare Part D.
Over 50 non-oncology GSK medicines are offered for use in an outpatient setting. GSK Oncology medicines are available through a separate program, Commitment to Access.
Basics of the program
Patients must meet certain eligibility
criteria to qualify for assistance and must enroll in Bridges
to Access with the help of an Advocate.
We’ve developed a telephone enrollment process that
allows initial eligibility determinations to be made quickly so
that patients may obtain their prescribed GSK medicines immediately
through any retail pharmacy of choice. See the Enrollment
for additional information.
|
